Back to calendar
Passage Bio, Inc. (PASG) Earnings
PASG reports earnings on Thursday, July 30, 2026
earnings report
July 30, 2026 · Before Market Open
Q2 2026
Est. EPS: $-2.27
Actual EPS: $-1.77
EPS surprise: 35.96%
Company overview
Market Cap$14.5M
PriceUSD 4.52
EPS (TTM)-11.84
52-week high20.00
52-week low3.29
SectorHealth Technology
IndustryBiotechnology
Employees24